Stay updated with breaking news from Michael Horowicz. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from BioNTech SE, BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors
BioNTech receives exclusive licenses from DualityBio for two investigational antibody-drug conjugate assets directed against targets expressed in a broad range of human cancersCollaboration will add... | April 3, 2023
BioNTech receives exclusive licenses from DualityBio for two investigational antibody-drug conjugate assets (DB-1303 and DB-1311) directed against targets...
Michael Horowicz: Good morning and afternoon. Thank you for joining us today for BioNTech's fourth quarter and full year 2022 earnings call.
MAINZ, Germany, March 28, 2023 -- BioNTech SE today announced that it has entered into a new share repurchase program , pursuant to which the Company may purchase American Depositary Shares,... | March 28, 2023